Jet-iStar 800 Analyzer
Jet-iStar 800 Plus Analyzer
JOINSTAR BIOMEDICAL TECHNOLOGY CO.,LTD
ECCMID 2023 | JOINSTAR INFECTION DISEASE BIOMARKERS SHOWCASED
by admin on 23-04-24
Joinstar attended the prestigious 33rd European Congress of Clinical Microbiology & Infectious Diseases, where the experts from all over the world gathered in Copenhagen. A key feature of the Congress was Sepsis and related inflammatory diseases in terms of their dia...
ISICEM 2023 (Belgium) JOINSTAR RAPID HBP TEST SHOWCASED
by admin on 23-04-03
At this International Critical Care meeting the Jet-iStar platforms (JS 800 and JS800 Plus) and the full range of Point-of-Care assays were presented with a special focus on Heparin Binding Protein (HBP), a novel patented biomarker which has been shown to play a key role in the management of Seps...
JOINSTAR | Brilliant success at MEDLAB 2023.
by admin on 23-02-18
The JOINSTAR products was a very positive response and got brilliant success which offerings in 【CoV-2 Influenza Antigen Rapid Test（3 in 1）】，【SARS-CoV-2 Influenza A&B RSV Antigen Combo Rapid Test（4 in1）】. However the main interest was on the Joinstar Rapid assay platforms 【Jet-iStar...
JOINSTAR joins the MDSAP Certification Community
by admin on 23-01-18
JOINSTAR is delighted to announce that it has successfully passed the “Medical Device Single Audit Program”(MDSAP) and has obtained the MDSAP quality system certificate issued by Societe Generale de Surveillance S.A. (SGS). The scope of certification covers the design, development, pr...
To all our partners
by admin on 22-11-24
#JOINSTAR | Thank you for being a part of our family and in turn letting us become a part of your’s. Thank you for your trust in the past and look forward to further cooperation in the future. This card can say more than a thousand words. Wish you and your family a wonderful Thanksgiving Day!
JOINSTAR | Warmly welcomed at MEDICA 2022.
by admin on 22-11-22
The JOINSTAR booth was attended by existing and new potential business partners from all over the world. Overall there was a very positive response for the JOINSTAR products and offerings in【COVID-19 Rapid Antigen Test】, 【CoV-2 Influenza Antigen Rapid Test（3 in 1）】，【Monkeypox Antigen Rapi...
INVITATION | MEDICA 2022
by admin on 22-11-11
#MEDICA2022 | #JOINSTAR waiting for you at H14/Hall 3, Düsseldorf, Germany, 14-17 Nov. 2022.
Exhibition Review | JOINSTAR successfully exhibits at the 2022 Medlab (Asia)
by admin on 22-11-05
JOINSTAR showcased the Jet-iStar platforms (JS 800 and JS800 Plus) and its full range of twenty one Point-of-Care assays covering a range of key diseases. A major focus was its wide range of the Infectious disease tests including the patented novel Heparin Binding Protein (HBP) assay, which has b...
Prospective Clinical Study | Joinstar Biomedical [COVID-19 Antigen Rapid Test Kit] Reported a Sensitivity of Up to 94.39%! ! !
by admin on 22-10-31
01 Locus Medicus Medical SA As the leading medical diagnostic center, blood disease investigation laboratory, and authoritative certification institution in the world, Locus Medicus Medical SA provides authoritative and professional certification in medical diagnostics for medical device enterpri...
JOINSTAR BIOMEDICAL TECHNOLOGY AT AACC CHICAGO 2022
by admin on 22-06-20
AACC 2022 Booth Location 763 Chicago 26-28 July 2022 JOINSTAR BIOMEDICAL TECHNOLOGY CO.LTD., are pleased to announce our participation at the AACC Exhibition in Chicago this year. We would be delighted to meet with you ...
HBP: from 2012 to 2022|Jet-iStar800|Returned to the laboratory at Lund University in Sweden
by admin on 22-04-06
In 2012, JOINSTAR obtained the application patent authorization of Heparin Binding Protein, becoming the exclusive Chinese enterprise to obtain the PATENT authorization of HBP. HBP was also introduced from Lund University in Sweden, Axis-Shield Diagnostics Ltd. The picture shows Dr. Adam Linde ...
Hit enter to search or ESC to close